Zoledronic acid prevents disuse osteopenia and augments gene expression of osteoclastic differentiation markers in mice

OBJECTIVES: Disuse is characterized by a rapid and profound bone resorption. Zoledronic acid (Zol) inhibits osteoclastic bone resorption. The aim of the study was to prevent disuse osteopenia with Zol and investigate gene expression markers of osteoclastic differentiation. METHODS: Disuse osteopenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Vegger, Jens Bay, Brüel, Annemarie, Thomsen, Jesper Skovhus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Musculoskeletal and Neuronal Interactions 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016491/
https://www.ncbi.nlm.nih.gov/pubmed/29855438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016491/
https://www.ncbi.nlm.nih.gov/pubmed/29855438

Ejemplares similares